Scientists Find out how to slow down biological aging

In an attempt to regenerate the Tirus gland, researchers from the University of California in Los Angeles may have found a solution that could slow down the aging process and even return it, a new study confirms. As part of a study in California, scientists tested a cocktail with three [...] drugs.
In an attempt to regenerate the Tirus gland, researchers from the University of California in Los Angeles may have found a solution that could slow down the aging process and even return it, a new study confirms.
As part of a study in California, scientists tested a cocktail with three common drugs ʹ growth hormone and two diabetes drugs in a year so as to stimulate the regeneration of the Timor gland.
However, according to a study published in Nature magazine, researchers found that participants lost an average of 2.5 years in their <x0 years of epigenetic”, as measured by a person's genes.
“We expected to slow down the biological clock, but not to return it,” said the researcher of UCLA Steve Horvat.
The “all looks like something introduced”, says Horvat for Nature.
Researchers warn that the findings are preliminary, as only nine participants were involved in the study and the study did not include a control group, but if health care impact is confirmed and the possibility of impact on aging may be great.
Epigenetic clock is measured by recording chemical changes in the structure of the body's DNA. The main purpose of the study was to prove ) whether the growth hormone can be used to regenerate tissue in the satus gland, which is essential to immune function. The gland begins to shrink after puberty.
Previous studies have shown that the growth hormone stimulates the regeneration of the imus, but it can also cause diabetes, so diabetes drugs are included in the latest study.
Researchers examined epigenetic hours in volunteers, concluding that the four different measures of epigenetic hours each of the participants changed significantly during the process.
This indicates that the biological effect of treatment is strong,” said Horvat.
Six participants gave blood samples six months after the test, and the effect remained the same, which made Horvat very optimistic about tests in the future.
Tests will include more different participants according to age, gender and nationality, and three drugs will be tested independently to determine specific effects.










